Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
HIV-AIDS
Marketing
Pfizer, Gilead, GSK to dominate infectious disease market
The infectious disease market is projected to grow by 5.7% through 2029, with Pfizer, Gilead and GSK expected to be the dominant forces in this market.
Ben Adams
Jul 20, 2023 9:45am
ViiV brings together sons and mothers in new initiative for HIV
May 30, 2023 7:15am
GSK's Cabenuva matches Gilead's Biktarvy in head-to-head study
Feb 22, 2023 11:00am
Gilead sponsors new 'HIV is not a crime' TV ad with André De Shields
Jan 4, 2023 9:05am
Pharma shuns digital and stays with TV for drug ads
May 24, 2022 9:15am
Gilead named top HIV philanthropic funder
May 20, 2022 10:03am
